![Mary Haak-Frendscho](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mary Haak-Frendscho
Direttore/Membro del Consiglio presso SURROZEN, INC.
Patrimonio netto: 28 560 $ in data 30/11/2024
Profilo
Mary Haak-Frendscho was the founder of Compugen, Inc. (United States) founded in 2012, where she served as Chairman until 2016.
Currently, she holds multiple positions including President, Chief Executive Officer & Director at Spotlight Therapeutics, Inc. since 2019, Director at Sirenas LLC since 2015, Director at Surrozen Operating, Inc. since 2021, and Independent Director at Surrozen, Inc. since 2021.
Dr. Haak-Frendscho's former positions include Chief Executive Officer & Director at Igenica Biotherapeutics, Inc. from 2012 to 2014, Chief Executive Officer & Director at Blueline Bioscience from 2016 to 2019, and President & Chief Scientific Officer at Takeda California, Inc. from 2008 to 2012.
She also served as a Principal at Genentech, Inc. and Abgenix, Inc., Director at Northern Biologics, Inc., and Chief Scientific Officer, VP-Preclinical R&D at XOMA Corp.
Dr. Haak-Frendscho was a Venture Partner at Versant Ventures Canada Ltd.
from 2017 to 2019.
Dr. Haak-Frendscho's education includes a graduate degree from the University of Washington, a graduate degree from Stony Brook University, a doctorate degree from the University of Wisconsin, and an undergraduate degree from the University of Michigan.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SURROZEN INC
0.07% | 10/04/2024 | 2 341 ( 0.07% ) | 28 560 $ | 30/11/2024 |
Posizioni attive di Mary Haak-Frendscho
| Società | Posizione | Inizio |
|---|---|---|
| SURROZEN, INC. | Direttore/Membro del Consiglio | 01/03/2021 |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Direttore/Membro del Consiglio | 11/03/2021 |
Spotlight Therapeutics, Inc.
 Spotlight Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Spotlight Therapeutics, Inc. engages in gene editing therapeutics. It focused in reprogramming tumor microenvironment. The company was founded by Alex Marson, Patrick Hsu, and Jacob Corn in 2017 and is headquartered in Hayward, CA. | Amministratore Delegato | 01/01/2019 |
Sirenas LLC
 Sirenas LLC Pharmaceuticals: MajorHealth Technology Sirenas LLC research and develops marine inspired pre-clinical leads for cancer, human immunodeficiency virus and infectious diseases. The company was founded by Jake Beverage, Eduardo Esquenazi and Phil Baran and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | 01/10/2015 |
Precedenti posizioni note di Mary Haak-Frendscho
| Società | Posizione | Fine |
|---|---|---|
Blueline Bioscience
 Blueline Bioscience Investment ManagersFinance Blueline Bioscience acts as an alternative investment manager. The company is headquartered in Toronto, Canada. | Amministratore Delegato | 01/01/2019 |
| Versant Ventures Canada Ltd. | Investitore di Private Equity | 01/01/2019 |
| Compugen, Inc. (United States) | Fondatore | 01/01/2016 |
Igenica Biotherapeutics, Inc.
 Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Amministratore Delegato | 01/01/2014 |
Takeda California, Inc.
 Takeda California, Inc. Pharmaceuticals: MajorHealth Technology Takeda California, Inc. is a pharmaceutical manufacturing company. The private company is based in San Diego, CA. | Presidente | 01/01/2012 |
Formazione di Mary Haak-Frendscho
| University of Michigan | Undergraduate Degree |
| University of Washington | Graduate Degree |
| University of Wisconsin | Doctorate Degree |
| Stony Brook University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| XOMA ROYALTY CORPORATION | Health Technology |
| SURROZEN, INC. | Health Technology |
| Aziende private | 11 |
|---|---|
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Health Technology |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Compugen, Inc. (United States) | |
Northern Biologics, Inc.
 Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | Health Services |
| Versant Ventures Canada Ltd. | Finance |
Blueline Bioscience
Blueline Bioscience Investment ManagersFinance Blueline Bioscience acts as an alternative investment manager. The company is headquartered in Toronto, Canada. | Finance |
Sirenas LLC
Sirenas LLC Pharmaceuticals: MajorHealth Technology Sirenas LLC research and develops marine inspired pre-clinical leads for cancer, human immunodeficiency virus and infectious diseases. The company was founded by Jake Beverage, Eduardo Esquenazi and Phil Baran and is headquartered in San Diego, CA. | Health Technology |
Spotlight Therapeutics, Inc.
Spotlight Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Spotlight Therapeutics, Inc. engages in gene editing therapeutics. It focused in reprogramming tumor microenvironment. The company was founded by Alex Marson, Patrick Hsu, and Jacob Corn in 2017 and is headquartered in Hayward, CA. | Health Technology |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Health Technology |
Takeda California, Inc.
Takeda California, Inc. Pharmaceuticals: MajorHealth Technology Takeda California, Inc. is a pharmaceutical manufacturing company. The private company is based in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Mary Haak-Frendscho
